glutathion et parkinson High Selectivity Fluorescence and Electrochemical Dual-Mode Detection of Glutathione in the Serum of Parkinson's Disease Model Mice and Humans Glutathione: subcellular distribution and membrane

Rosendahl Huber, A

Trends related to aging and co-occurring disorders in HIV-infected drug users

The review thoroughly examines both clinical and practical evidence regarding the use of c-MET inhibitors alongside PD-1/PD-L1 inhibitors, emphasizing that focusing on c-MET with immunotherapy enhances the effectiveness of treating MET tumors exhibiting elevated PD-L1 expression

[DOI] [PMC free article] [PubMed] [Google Scholar] [132].Chen X, Li J, Kang R, et al

(Yale University) There is clear evidence in adults with T1D that GLP-1 receptor agonists can improve weight and glycemic control and reduce the risk of heart and kidney complications, and more clinical evidence is needed for the adolescent population

JCI Insight 4 (17), e129920